Resources Calendar
SFG is pleased to connect our members with associated meetings of interest. If you know of a meeting that may be of interest to the membership, please email the information to for inclusion in this listing.


2018 NIH & FDA Glycoscience Day

April 6, 2018

2018 NIH & FDA Glycoscience Day

July 13, 2018
Natcher Conference Center
Bethesda, Maryland
Dr. Pamela Marino, NIGMS, NIH
Dr. Willie Vann, CBER, FDA
Expected Speakers
Cell signaling through O-GlcNAc-binding proteins
Dr. Michael Boyce, Assistant Professor, Department of Biochemistry, Duke University Medical Center
Mapping and manipulating O-GlcNAc during primary human T cell activation
Dr. Christina Woo, Assistant Professor, Department of Chemistry and Chemical Biology,Harvard University
Diversity of Glycosylation Analysis Methods in Monoclonal Antibodies: a NIST Interlaboratory Study
Dr. Lorna De Leoz, Chemical Reference Data Group, Mass Spectrometry Data Center, NIST  
Checking Cellular IDs with Human Lectins
Dr. Laura Kiessling, Novartis Professor of Chemistry, Department of Chemistry,Massachusetts Institute of Technology
Chemical Tools to Probe the Dynamics of the Bacterial Peptidoglycan
Dr. Catherine Grimes, Assistant Professor, Department of Chemistry, University of Delaware
Elucidating the Catalytic Mechanism of Neisseria meningitidis C Polysialyltransferase
Dr. Shonoi Ming, Laboratory of Bacterial Polysaccharides, OVRR, CBER, FDA
Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120
Dr. James Arthos, Laboratory of Immunoregulation, NIAID
Glycan recognition at the fusion peptide-site of HIV-1 vulnerability
Dr. Peter Kwong, Chief, Structural Biology Section & Structural Bioinformatics Core, VRC, NIAID
Development of NIST SRM 3655 – Glycans in Solution: Applications to quantifying glycosylation for antibody therapeutics
Dr. Mark Lowenthal, Research Chemist, NIST
Preclinical, Regulatory and Clinical Development of ManNAc as a Therapy for GNE Myopathy
Dr. Marjan Huizing, Clinical Project Manager & Staff Scientist, NHGRI &
Dr. Nuria Carrillo, Staff Clinician, NHGRI
ST6Gal-I sialyltransferase promotes tumor metastasis by conferring a cancer stem cell phenotype
Dr. Susan Bellis, Professor, Cell Developmental and Integrative Biology, University of Alabama School of Medicine
Characterization of Recombinant Human Core 3 b3-N-Acetylglucosaminyltransferase Reveals its Novel Activity
Dr. Tongzhong Ju, Principal Investigator, CDER, FDA
Structural insights into substrate recognition by Polypeptide N-Acetylgalactosamine Transferases (GalNAc-Ts)
Dr. Nadine Samara, Staff Scientist, NIDCR

Abstracts will be due June 1, 2018
Poster talks will be selected from Abstracts


Upcoming Meeting: Benzon Symposium No. 64

March 28, 2018
We would like to draw your attention to the upcoming Benzon Symposium No. 64:
Copenhagen, August 27-30, 2018

Organizing committee: Henrik Clausen, Hans H. Wedell, Steffen Thiel, James Paulson, Nico Callewaert, Finn Cilius Nielsen and Hans Bräuner-Osbrone
Venue: Hotel Skt Petri, Krystalgade 22, 1172 Copenhagen

The Benzon Symposia are international conferences on front line research in medical, pharmaceutical, and related sciences funded by the Alfred Benzon Foundation.
The concept of the 64th Benzon Symposium on Glycotherapeutics – Emerging Roles of Glycans in Medicine is to bring together the world’s leading scientists working on complex carbohydrates with clear translational drug and therapeutic perspectives. With this symposium, we aim to encompass as many aspects of glycans and therapeutic applications as possible in order to stimulate new ideas, interactions and synergies, and to foster further excitement and developments in this field. We hope to create an intense and interactive environment for both experienced and young scientists with a mixture of invited and selected presentations from participants. A key objective is to bring together leading scientists from different disciplines working with therapeutic options involving glycans and the different technologies that enable discovery and production of glycotherapeutics.
We believe the symposium will bring improved understanding and appreciation of the wide opportunities of glycans in drug development and introduce advancements in innovative technologies applicable to the field.
GlcNAcylation & diseases
Congenital diseases of glycosylation & therapeutic options
Immunology & therapeutic options
Glycome & Microbiome
Engineering glycosylation in cells
Platform technologies for advancing glyco-drugs
Symposium No. 64 will feature state-of-the art lectures by 24 world-leading scientists, who have made groundbreaking contributions to the field of glycoscience and glycotherapeutics. The Benzon Symposium will further include 16 oral presentations selected from submitted abstracts for poster presentations. Attendance will be limited to 150 scientific participants in total, and all attendees will be accommodated at the Hotel Skt. Petri ( located in the center of Copenhagen (Denmark) for the entire event.
Confirmed invited speakers:
Ajit Varki (US), Gerald W. Hart (US), John A. Hanover (US), Hudson H. Freeze (US), Robert S. Haltiwanger (US), James C. Paulson (US), Carl June (US), Max Crispin (UK), Richard D. Cummings (US), Gunnar C. Hansson (S), Jamey D. Marth (US), Nico Callewaert (BE), Herta Steinkellner (AT), Rita Gerardy-Schahn (DE), Robert Sackstein (US), Daan van Aalten (UK), Tadashi Suzuky (JP), Dennis Burton (US), Michael Kowarik (CH), Falk Nimmerjahn (DE), Mark von Itzstein (AU), Jeffrey D. Esko (US), Linda Hsieh-Wilson (US)
Submission round opens: April 1, 2018
Submission round closes: May 1st, 2018
Registration: (provided acceptance of abstract) June 1, 2018
Fee: DKK 4,500 (scientific meeting, hotel accommodation, food & social events)
No discount is given to local delegates
Further information:
Leila Majdanac
The Alfred Benzon Foundation
C /O Copenhagen University
Faculty of Health and Medical Sciences
School of Pharmaceutical Sciences
Universitetsparken 2
DK-2100 Copenhagen
Phone: +45 2297 8752



March 23, 2018


November 5-8, 2018

1st Human Glycome Project Meeting and the 2nd GlycoCom Conference

March 5, 2018

Dear Friends,
We would like to invite you to join us in Dubrovnik, Croatia on October 3-6, 2018 for the 1st Human Glycome Project Meeting and the 2nd GlycoCom Conference that will be held jointly this year.
The Glycosciences have clearly made an impact beyond the isolated research laboratories and are now exhibiting applications in the development of new drugs, vaccines and diagnostic tools. On the whole, this is being driven by numerous companies that have dynamic R&D programs in diverse areas of the glycosciences. Therefore, after a successful inaugural GlycoCom conference in Banff, Canada in May 2015, we are now organizing a second meeting focused on highlighting new developments that have occurred during the interactions between academic and industrial researchers in this area.
Together with the 2nd GlycoCom Conference, we will organize the 1st Human Glycome Project Meeting.  Thanks to recent developments in instrumentation and analytical methods, we believe that both the structural definition of all human glycans and the determination of the glycome variability between different individuals in both health and disease are now realistic goals. Therefore the time is right to establish a program that will coordinate efforts of individual academic and industrial laboratories in this field.
We hope that you will be able to join us in Dubrovnik next October and enjoy both the excellent science and the magnificent scenery of the warm Adriatic Sea.
Your organizers,
Gordan Lauc               Christine Szymanski               Richard Cummings                              Abstract submission


29th International Carbohydrate Symposium (ICS 2018) in Lisbon July 15-19 preceded by the ICS Iberain Day on July 14th

March 5, 2018

The organizing committee of the 29th International Carbohydrate Symposium (ICS 2018) is delighted to announce this meeting, endorsed by IUPAC, to be held from the 15th to the 19th of July at Faculdade de Ciências, Universidade de Lisboa (FCUL). The Roy Whistler Award Lecture by David Crich (Wayne State University), and the ICO Young Researcher Award Lecture will be given in the opening session on July 15th. In the morning of the same day, the Young Researcher Workshop will be organized, co-sponsored by CarboMet, aiming to bring together the young participants of ICS 2018. As a pre-symposium on July 14th, recent findings in glycochemistry and glycobiology will also be presented at the ICS Iberian Day.

For more details, please visit:

The scientific sessions cover emerging areas of glycosciences, lectured by the world's most prestigious experts.  Presentations in all areas in which carbohydrates play a key role are welcome, namely in personalized medicine, glycosylation and disease, vaccines, prebiotics, in particular for infants, gut microbiota, nutrition, cosmetics, natural products embodying carbohydrates, glycomaterials, polysaccharide biotechnology, lignocellulosic biomass valorization, and glycoinformatics and of course synthesis, analysis and biomolecule structure.
Highlight-worthy is the organ concert, free for participants and registered accompanying persons, that is played at the Basilica of the Palace of Mafra, which six pipe organs are widely known around the world. They are a unique organ ensemble originally conceived to play together, completed in 1807 and restored several times along the centuries.
Gala dinner will be at Casino Estoril, partially sponsored by the Organizing Committee of ICS 2018.
The Organizing Committee is pleased to invite you to join this Symposium, sharing your expertise in this networking forum with leading scientists from academia and industry, particularly dedicated to the young researchers! The deadline for early bird registration is the 4th of May, and the deadline for abstract submission is the 18th of May.
Join us in this beautiful city of  Lisbon, embraced by a golden sun, and inspired by Tagus river, running into our billowy sea!